“That’s the world we are living in.”“Until there is evidence, there is no reason at all to be issuing public health guidance” about Nsaids and the coronavirus, he added.
There are reasons to worry about long-term, heavy use of Nsaids, which have been linked an increased risk of kidney damage in some patients.
But for infectious disease specialists, the greater concern is that when Nsaids and acetaminophen reduce fever, patients may be more comfortable but their lower temperatures can short-circuit the body’s main defense against infection.
The immune system works better when the body’s temperature is higher, enabling it to more efficiently kill viruses and bacteria.
Dozens of studies — in animals, reptiles and humans — have found that fever is beneficial in fighting infections.